Investor Caxton Corp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Caxton Corp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-02-13 13G/A SCYX / SCYNEXIS, Inc. 2,210,672 0
2024-02-13 13G/A SVRA / Savara Inc. 6,896,551 353,441
2023-02-14 13G/A RZLT / Rezolute, Inc. 1,333,473 1,860,518
2023-02-14 13G/A CRDF / Cardiff Oncology, Inc. 3,479,340 983,607
2023-02-14 13G/A ADXN / Addex Therapeutics Ltd 718,849
2023-02-14 13G/A XERS / Xeris Biopharma Holdings, Inc. 7,829,682 5,973,324
2022-02-14 13G/A ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock) 2,314,489
2022-02-14 13G/A CRDF / Cardiff Oncology, Inc. 3,098,447 3,479,340
2022-02-14 13G/A SCYX / SCYNEXIS, Inc. 1,474,370 2,210,672
2022-02-14 13G/A RZLT / Rezolute, Inc. 564,243 1,333,473
2022-02-14 13G/A CTIC / CTI BioPharma Corp 3,749,890 2,239,300
2022-02-14 13G/A SRRA / Sierra Oncology Inc 1,142,361 1,119,322
2022-02-14 13G/A SVRA / Savara Inc. 6,896,551 6,896,551
2022-01-05 13D/A SBBP / Strongbridge Biopharma plc 10,280,682 0
2022-01-05 13G XERS / Xeris Biopharma Holdings, Inc. 7,829,682
2021-03-19 13G SVRA / Savara Inc. 6,896,551
2021-02-16 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 8,134,926 0
2021-02-16 13G/A SCYX / SCYNEXIS, Inc. 7,936,111 1,474,370
2021-02-16 13G/A SRRA / Sierra Oncology Inc 1,082,200 1,142,361
2021-02-16 13G/A CRDF / Cardiff Oncology, Inc. 1,958,243 3,098,447
2021-02-16 13G/A CTIC / CTI BioPharma Corp 4,487,317 3,749,890
2021-02-16 13G ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock) 2,316,293
2020-10-14 13G RZLT / Rezolute, Inc. 564,243
2020-10-02 13G CTIC / CTI BioPharma Corp 4,487,317 4,487,317
2020-10-01 13G CTIC / CTI BioPharma Corp 4,487,317
2020-09-23 13D/A SBBP / Strongbridge Biopharma plc 8,514,829 10,280,682
2020-06-22 13G CRDF / Cardiff Oncology, Inc. 1,958,243
2020-02-14 13G/A SCYX / SCYNEXIS, Inc. 4,325,000 7,936,111
2020-02-14 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 5,345,826 8,134,926
2020-02-14 13G/A US3665541039 / Garrison Capital Inc. 1,217,722 1,223,096
2020-02-14 13G/A ABDC / Altmore BDC Inc 767,000 1,005,000
2020-02-14 13G/A 859319303 / Sterling Financial Corp 659,252
2020-02-14 13G/A ICMB / Investcorp Credit Management BDC, Inc. 0
2020-02-03 13G SRRA / Sierra Oncology Inc 1,082,200
2019-10-21 13G 859319303 / Sterling Financial Corp 870,820
2019-07-19 13G 867328601 / Sunesis Pharmaceuticals, Inc. 5,345,826
2019-02-14 13G/A MEIP / MEI Pharma, Inc. 6,600,658 3,459,124
2019-02-14 13G/A US3665541039 / Garrison Capital Inc. 1,089,834 1,217,722
2019-02-14 13G/A SCYX / SCYNEXIS, Inc. 4,870,409 4,325,000
2019-02-14 13G/A ICMB / Investcorp Credit Management BDC, Inc. 722,746 1,028,355
2019-02-04 13G ABDC / Altmore BDC Inc 767,000
2018-08-27 13D/A SBBP / Strongbridge Biopharma plc 7,614,994 8,514,829
2018-05-25 13G MEIP / MEI Pharma, Inc. 6,600,658
2018-05-22 13G/A AGRX / Agile Therapeutics, Inc. 1,823,012 671,823
2018-03-13 13G SCYX / SCYNEXIS, Inc. 4,870,409
2018-02-14 13G/A AGRX / Agile Therapeutics, Inc. 1,819,612 1,823,012
2018-02-14 13G/A US3665541039 / Garrison Capital Inc. 830,568 1,089,834
2018-01-02 13G ICMB / Investcorp Credit Management BDC, Inc. 722,746
2017-10-10 13D/A SBBP / Strongbridge Biopharma plc 5,394,994 7,614,994
2017-08-18 13G AGRX / Agile Therapeutics, Inc. 1,654,317 1,819,612
2017-08-04 13G/A AGRX / Agile Therapeutics, Inc. 2,123,567 1,654,317
2017-08-01 13G US3665541039 / Garrison Capital Inc. 830,568
2017-02-06 13G/A AGRX / Agile Therapeutics, Inc. 1,561,333 2,123,567
2016-12-30 13D SBBP / Strongbridge Biopharma plc 5,394,994
2016-08-01 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 622,448 522,772
2016-08-01 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 622,448 522,772
2016-07-26 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 21,842,662 622,448
2016-07-26 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 21,842,662 622,448
2016-07-15 13D/A PATI / Patriot Transportation Holding, Inc. 3,156,322 0
2016-06-22 13D/A PATI / Patriot Transportation Holding, Inc. 3,246,819 3,156,322
2016-06-01 13D/A PATI / Patriot Transportation Holding, Inc. 3,246,819 3,246,819
2016-04-29 13G AGRX / Agile Therapeutics, Inc. 1,561,333
2016-04-22 13D/A PATI / Patriot Transportation Holding, Inc. 3,246,819
2016-04-15 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 21,784,805 21,842,662
2015-12-09 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 23,154,544 21,784,805
2015-12-07 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 24,738,904 23,154,544
2015-12-01 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 24,738,904
2014-11-26 13D/A PATI / Patriot Transportation Holding, Inc. 3,097,067
2013-12-16 13D/A MDGL / Madrigal Pharmaceuticals, Inc. 28,668,849